XML 49 R38.htm IDEA: XBRL DOCUMENT v3.22.2
Stock-based compensation (Tables)
6 Months Ended
Jun. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of assumptions used to determine the grant-date fair value of stock options

The following table presents, on a weighted average basis, the assumptions used in the Black-Scholes option-pricing model to determine the grant-date fair value of stock options granted to employees and directors:

Three Months Ended June 30, 

 

Six Months Ended June 30, 

 

    

2022

    

2021

 

2022

    

2021

 

Risk-free interest rate

 

2.85

%  

1.1

%

2.00

%  

1.0

%

Expected term (in years)

 

5.9

 

6.1

6.0

 

6.0

Expected volatility

 

43.9

%  

43.1

%

43.1

%  

44.3

%

Expected dividend yield

 

0

%  

0

%

0

%  

0

%

Schedule of stock option activity

The following table summarizes the Company’s stock option activity since December 31, 2021:

Weighted 

Weighted 

average 

Number of 

average 

remaining 

Aggregate 

    

shares

    

exercise price

    

contractual term

    

intrinsic value

(in years)

(in thousands)

Outstanding as of December 31, 2021

 

4,823,100

$

5.06

 

7.62

$

31,041

Granted

 

1,542,759

 

7.53

Exercised

 

(475,033)

 

0.99

Expired

 

(5,546)

 

10.74

Forfeited

 

(212,152)

 

11.85

Outstanding as of June 30, 2022

 

5,673,128

$

5.79

8.15

$

9,010

Options vested and expected to vest as of June 30, 2022

 

5,673,128

$

5.79

8.15

$

9,010

Options exercisable as of June 30, 2022

 

2,426,101

$

2.72

6.78

$

6,687

Schedule of restricted stock activity

The following table summarizes the Company’s restricted stock activity since December 31, 2021:

Weighted 

Number of 

average 

    

shares

    

fair value

Unvested as of December 31, 2021

248,903

$

2.10

Granted

-

-

Vested

(82,967)

$

2.10

Forfeited

-

-

Unvested as of June 30, 2022

165,936

$

2.10

Schedule of assumptions used to determine fair value of 2021 ESPP The following weighted average assumptions were used in the calculation of fair value of shares under the 2021 ESPP at the grant date for the three and six months ended June 30, 2022 (there were no offering periods for the three and six months ended June 30, 2021):

Three Months Ended June 30, 

Six Months Ended June 30, 

2022

2022

Risk-free interest rate

0.86

%  

0.86

%  

Expected term (in years)

 

0.5

 

 

0.5

 

Expected volatility

 

43.1

%  

 

43.1

%  

Expected dividend yield

 

0

%  

 

0

%  

Schedule of stock-based compensation expense was classified in the consolidated statements of operations

Stock-based compensation

Stock-based compensation expense was classified in the condensed consolidated statements of operations as follows (in thousands):

    

Three Months Ended June 30, 

    

Six Months Ended June 30, 

    

2022

    

2021

    

2022

    

2021

Cost of revenue

$

164

$

85

$

264

$

115

Research and development

 

100

 

37

 

179

 

49

Sales and marketing

 

142

 

60

 

276

 

82

General and administrative

 

852

 

208

 

1,522

 

335

Total stock-based compensation expense

$

1,258

$

390

$

2,241

$

581

Restricted Stock Units  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of restricted stock activity The following table summarizes restricted stock units granted to Company employees during the six months ended June 30, 2022:

Weighted 

Number of 

average 

    

shares

    

fair value

Unvested as of December 31, 2021

-

$

-

Granted

593,480

7.62

Vested

-

-

Forfeited

(9,600)

7.58

Unvested as of June 30, 2022

583,880

$

7.62